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Abstract
Background: Littoral cell angioma (LCA) is a recently described primary vascular neoplasm of the
spleen that may be associated with other malignancies and may itself also have malignant potential.
Case presentation: We present a case of LCA that was discovered incidentally in a 52-year-old
woman who presented with biliary colic at the time of consultation for cholecystectomy. This
vascular neoplasm was evaluated by ultrasound, CT, MRI, Tc-99m labelled red blood cell
scintigraphy, and core biopsy. A splenectomy revealed LCA by pathological evaluation. Post-
operative outcome was favourable with no evidence of complication or recurrent disease.
Following this case presentation, clinical, radiographic, and pathological features of LCA will be
reviewed as well as recent advances in our understanding of this uncommon splenic lesion.
Conclusion: LCA is a rare, generally benign, primary vascular tumour of the spleen that typically
is discovered incidentally. Individuals diagnosed with this tumour must be carefully evaluated to
exclude primary, secondary, and synchronous malignancies.
Background
Littoral Cell Angioma (LCA) of the spleen was recently
described by Falk et al. in 1991 [1]. This group reviewed
200 surgical specimens of benign vascular splenic
tumours and found 17 similar tumours that appeared
related to the cells lining the red pulp splenic sinuses [1].
These tumours were unique in that they displayed both
epithelial and histiocytic properties based on their cell of
origin, the splenic littoral cells [1]. From these observa-
tions, this group designated this new vascular tumour of
the spleen LCA [1].
Since this initial description, there have been scattered
case reports and few case series of LCA [2-10]. The clinical
presentation of LCA ranges from being completely asymp-
tomatic and discovered incidentally, to presenting with a
constellation of signs and symptoms such as abdominal
pain, vague constitutional symptoms, splenomegaly, and
hypersplenism [2-6]. Although first described as benign,
LCA has recently been shown to exhibit malignant poten-
tial [11,12] and may also be associated with other visceral
malignancies [13]. In this report, we present a case of LCA
including its diagnostic work-up, surgical treatment, path-
ological evaluation, and post-operative outcome. A dis-
cussion regarding the clinical, radiological, and
pathological features of LCA, as well recent advances in
our understanding of this uncommon splenic tumour are
also presented.
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Case presentation
A 52-year-old woman was evaluated for symptoms of bil-
iary colic for possible cholecystectomy. She described
intermittent episodes of right upper quadrant pain with
no history of jaundice, nausea, vomiting, or changes in
bowel habits. Laboratory tests revealed elevated liver
enzymes of a cholestatic nature but total bilirubin within
normal limits (ALP = 139 U/L, GGT = 67 U/L, total
bilirubin = 6 μmol/L). Haemoglobin, white blood cells,
and platelet counts were within normal limits. Ultra-
sound (US) revealed cholelithiasis, a normal appearing
biliary tree, and fatty infiltration of the liver. Notably, US
also identified a hyperechoic, well-circumscribed, 3 cm
lesion located at the inferior aspect of the spleen (figure
1). No significant vascularity was noted on the color Dop-
pler images.
The splenic lesion was further evaluated with CT, MRI. A
hypodense well defined lesion with some internal
enhancement in the arterial and venous phases was dem-
onstrated on the contrast enhanced CT scan (Fig. 2A, 2B).
The lesion was isodense compared to the surrounding
splenic parenchyma on the 5 minutes delayed images
(Fig. 2C). On MR, the lesion was hypointense on the T1,
and hyperintense on the T2-weighted sequences (Fig. 3A).
After the administration of IV gadolinium the lesion dem-
onstrated some internal linear enhancement in the portal
venous phase on the T1-weighted fat suppressed sequence
(Fig. 3B) and became isointense on the delayed images. A
Tc-99m labelled red blood cell scan showed the splenic
lesion to be 'cold'. A percutaneous ultrasound guided core
biopsy of the lesion was subsequently carried out but was
nondiagnostic as histological evaluation showed skeletal
muscle. Overall, it was felt that the splenic lesion had a
benign appearance and would be followed up with imag-
ing.
A laparoscopic cholecystectomy was performed. No
splenic lesion was grossly evident at the time of laparos-
copy. The postoperative course was uneventful and epi-
sodes of abdominal pain resolved post-operatively. A
colonoscopy was also performed, which was normal. A
repeat CT scan 6 months postoperatively showed interval
enlargement of the splenic lesion as well as the develop-
ment of an adjacent satellite lesion with a similar radio-
logical appearance. As a result of the enlargement of the
lesion, and development of a new lesion, a decision was
made to carry out a splenectomy.
At the time of open splenectomy, the spleen was unre-
markable in terms of size and appearance, and was
removed in its entirety for pathological evaluation. This
patient had an uneventful post-operative recovery and has
remained well at fifteen months of post-operative follow-
up. Pathologic evaluation identified a non-encapsulated
but well-circumscribed reddish nodule that was 4 × 3 × 3
cm in size and located at the anterior-inferior pole of the
spleen. Histologically, this lesion was described as a vas-
cular neoplasm forming anastomosing vascular channels
lined by histiocytes with occasional papillary structure,
consistent with Littoral Cell Angioma (Fig. 4).
Discussion
Primary vascular tumours of the spleen are uncommon
but represent the majority of non-hematolymphoid
splenic tumours [14]. The differential diagnosis of splenic
vascular tumours is broad and may represent benign (hae-
mangioma, haemartoma, lymphangioma), indeterminate
(littoral cell angioma, haemangioendothelioma, haeman-
giopericytoma), or malignant neoplasms (angiosarcoma)
[14]. LCA is a recently described vascular tumour of the
spleen that is now classified as having uncertain biological
behaviour, given several case reports which have identi-
fied malignant potential [14].
The exact incidence of LCA is unknown although the inci-
dence of splenic haemangioma varies from 0.03% to as
high as 14% in one reported autopsy series [15]. LCA does
not have any particular gender or age predilection
although the median age in Falk et al.,'s original study of
LCA was 49 years [1,14]. As was the case for our patient,
LCA may be completely asymptomatic and represent an
incidental finding by imaging [13,16]. LCA may also
present with a myriad of possible signs and symptoms,
such as: splenomegaly with or without abdominal pain,
hypersplenism with ensuing anaemia and/or thrombocy-
topenia, and constitutional symptoms such as intermit-
Ultrasound of the spleen demonstrates a well-defined hyper- echoic lesion Figure 1
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tent fevers. More dramatically, LCA has been reported to
present as splenic rupture and haemoperitoneum [13-15].
LCAs are believed to originate from the littoral cells, the
cells that line red pulp sinuses of the spleen [1,17]. From
studies performed as far back as the 1930s, endothelial
cells lining the vascular sinuses of the spleen were consid-
ered unique in that they exhibited both phagocytic and
hematopoietic properties [10]. Neoplasia of these cells
results in the formation of LCA, which exhibit histologic
and molecular features consistent with both these epithe-
lial and histiocytic cell types [17,18].
The pathogenesis of LCA remains unclear, but given its
association with autoimmune disorders such as Crohn's
disease and inborn metabolic diseases such as Gaucher's
disease, immune system dysfunction has been postulated
as a possible important pathogenic mechanism [10,19].
Supporting this hypothesis, other reports have suggested
that chronic infection and systemic immunosuppression
may contribute to LCA development [13,18].
Indeed, immune system dysregulation may explain the
association of LCA with other cancer types. The other can-
cer types associated with LCA include: thyroid, colorectal,
renal, pancreatic, hematologic (lymphoma), ovarian, and
testicular cancer [10,13,18,20,21]. These observations
CT scan after oral and iv-contrast in the arterial phase A and portal venous phase B demonstrates a hypodense well defined  round lesion in the posterior portion of the spleen with some linear internal enhancement Figure 2
CT scan after oral and iv-contrast in the arterial phase A and portal venous phase B demonstrates a hypodense well defined 
round lesion in the posterior portion of the spleen with some linear internal enhancement. C. The lesion is isodense compared 
to the normal spleen on the 5 minutes delayed image.
A. The lesion is hyperintense on the T2 weighted fast recovery fast spin echo (FRFSE) image Figure 3
A. The lesion is hyperintense on the T2 weighted fast recovery fast spin echo (FRFSE) image. B. Internal linear enhancement is 
noted on the T1 weighted fat saturated image after iv-gadolinium in the portal venous phase.World Journal of Surgical Oncology 2008, 6:87 http://www.wjso.com/content/6/1/87
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have prompted recommendations to closely evaluate and
provide surveillance to patients with LCA for the develop-
ment of other malignancies [20]. Conversely, the associa-
tion of LCA with other cancer types may also be a result of
making an incidental diagnosis of LCA during extensive
radiological imaging for other diseases, given the largely
asymptomatic presentation of these tumours [22].
However, close follow-up of LCA may be warranted due to
the potential for their malignant transformation. The two
subtypes of LCA with malignant potential have been
described as "littoral cell angiosarcoma" [18,23,24] and
"littoral cell haemangioendothelioma" [11,12,18]. These
LCA variants may present with distant metastasis several
months after splenectomy; histologic evaluation reveals
features consistent with LCA histopathology as well as
abnormal architecture, nuclear atypia, and necrosis
[11,12,23,24].
Radiologically, LCA may be evaluated by several imaging
modalities such as US, CT, MRI, or nuclear medicine stud-
ies (Tc-99m labelled RBC scintigraphy). US may reveal
lobular splenomegaly with heterogeneous nodules (either
hypo- or hyper-echoic) that may be solitary or multiple
(Figure 1) [25]. On non-contrast CT, LCA appear as hypo-
attenuating masses; given the vascular nature of these neo-
plasms, they tend to enhance homogeneously. On MRI, a
minority of cases may be hypointense on both T1-
weighted and T2-weighted scans because of hemosiderin
content of the tumour [14]. However, as significant
siderosis is seen in less than 50% of LCA cases [1], lesions
tend to be hyperintense on the T2 weighted images, as was
the case in our patient (Figure 3) [26]. Nuclear medicine
studies with Tc-99m labelled RBC scintigraphy can be use-
ful to differentiate splenic lesions from splenic haemangi-
omas [27,28]. However, the radiologic features of LCA are
rarely diagnostic since many other splenic neoplasms
such as haemartomas, haemangiomas, lymphomas, met-
astatic disease and infectious processes exhibit similar
imaging characteristics [29].
Gross pathology of LCA is characterized by single, or more
commonly, multiple pigmented focal nodules well-delin-
eated from normal spleen parenchyma [28,30]. The col-
our of these nodules may be dark red, brown, or black,
consistent with blood or blood products of varying chro-
nicity [28]. Rarely, LCA appears white on gross pathology
[1,30]. The size of these lesions varies and may range from
0.1 cm to 11 cm in diameter [1,30,31]. The spleen itself
may appear grossly enlarged or, as was true for our case,
look otherwise unremarkable [31,32].
Microscopically, there are several distinguishing histolog-
ical and molecular features of LCA. Histologically, LCA
has specific features that differentiate it from other pri-
mary vascular tumours, including angiosarcoma [1]. LCA
are composed of anastomosing vascular channels resem-
bling splenic sinusoids and have irregular lumina featur-
ing papillary projections and cyst-like spaces (Figure 4)
[1]. Tall endothelial cells with histiocytic properties that
slough off into the vascular lumen are common, as is the
absence of atypical cells and presence of low mitotic activ-
ity [1]. By immunohistochemical staining, these tumour
cells will express endothelial and histiocyte antigens, a
reflection of the distinct dual differentiation potential of
LCA [1]. Such expression includes endothelial markers
(factor VIII Ag and CD 31/BMA 120) as well as histiocytic
markers (CD 68/KP 1 and lysozyme) [1,4,30,31,33]. The
expression of these molecular markers has also been dem-
onstrated in fine-needle aspiration biopsies of LCA [33].
Symptomatic LCA are often relieved by splenectomy, and
given the association of LCA with other malignancies and
reported cases of metastasizing LCA, splenectomy is both
diagnostic and therapeutic. While there have been reports
of medical therapy with glucocorticoids and angioembol-
ization of splenic haemangiomas [34], splenectomy is still
considered the gold standard for treatment of vascular
splenic tumours [15].
Conclusion
LCA is a recently described primary vascular neoplasm of
the spleen that may be associated with other malignancies
and may itself also have malignant potential. Several radi-
ological studies may suggest LCA, although a pathological
diagnosis, either by core biopsy or diagnostic splenectomy
is imperative. This rare case illustrates the importance of
thoroughly evaluating incidental vascular splenic
Anastamosing vascular channels lined by plump cells with the  appearance of sinus lining (arrow: 'littoral' cells) (H&E 100×) Figure 4
Anastamosing vascular channels lined by plump cells with the 
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tumours. Although the vast majority of LCAs are benign,
their differential diagnosis must include both primary and
secondary malignancy, given LCA's association with other
cancer types as well as their uncertain malignant poten-
tial. With this in mind, gold standard management
remains splenectomy and long-term follow-up for the
development of synchronous tumours or metastatic
lesions is advised.
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